|
Summary:
the customer ((b)(6) japan) reported a potential false positive mrej and meca/c (methicillin-resistant staphylococcus aureus) result on the biofire® blood culture identification 2 (bcid2) panel after testing a patient blood culture bottle sample.The customer reported that due to the bcid2 panel result, the patient was indirectly impacted, specifically by inappropriate treatment, which might lead to serious injury if it were to recur.The customer stated that the patient was not harmed.Biofire has requested further information from the customer and is currently investigating this event.No remedial action, corrective action, preventive action, or field safety corrective action (fsca) has been deemed necessary at this time.
|